Product Information |
|
Registration Number |
BR-1452
|
Generic Name |
Pneumococcal Polysaccharide Conjugate Vaccine, 13-
Valent (Adsorbed)
|
Brand Name |
Pneumocon 13
|
Dosage Strength |
Each dose (0.5 mL) contains the capsular polysaccharide of the following Streptococcus pneumoniae serotypes: Pneumococcal Polysaccharide Serotype 6B
Pneumococcal Polysaccharide Serotype 18C
Pneumococcal Polysaccharide Serotype 4, 23F
Pneumococcal Polysaccharide Serotype 7F Pneumococcal Polysaccharide Serotype 14, 19F Pneumococcal Polysaccharide Serotype 1, 19A Pneumococcal Polysaccharide Serotype 3, 5, 6A, 9V
Conjugated to Tetanus Toxoid carrier protein
6.0 με
3.25 μg
3.0 με
2.85 μg
2.75 μg
2.6 μg
|
Dosage Form |
Suspension for Injection (IM)
|
Classification |
Prescription Drug (RX)
|
Pharmacologic Category |
-
|
Packaging |
0.5 mL in 1 mL borosilicate glass vial with chlorinated butyl rubber stopper and combined aluminum-plastic cap (Box of 20's)
|
Manufacturer |
Yuxi Walvax Biotechnology Co., Ltd.
|
Country of Origin |
China
|
Trader |
N/A
|
Importer |
2 World Traders Inc.
|
Distributor |
2 World Traders Inc.
|
Application Type |
Monitored Release (MR) [Reapplication]
|
Issuance Date |
03 November 2023
|
Expiry Date |
03 November 2028
|